Skip to main content
. 2016 Sep 2;7(43):70185–70193. doi: 10.18632/oncotarget.11824

Figure 1. Study selection flow about the cisplatin-based chemoradiotherapy of head and neck cancer.

Figure 1

CNKI = China National Knowledge Infrastructure.